AI
LENZ

Acuitas Investments’s LENZ Therapeutics LENZ Stock Holding History

Acuitas Investments’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-31,488
Closed -$703K – 132
2024
Q1 		$703K Buy
31,488
+3,691
+13% +$76.7K 0.35% 84
2023
Q4 		$621K Sell
27,797
-169
-0.6% -$2.79K 0.32% 90
2023
Q3 		$485K Sell
27,966
-1
-0% -$17 0.29% 82
2023
Q2 		$509K Buy
+27,967
New +$559K 0.3% 85

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Acuitas Investments's LENZ Position: Q2 2024 in Review

Acuitas Investments sold out of LENZ Therapeutics (LENZ) in Q2 2024, closing a stake of 31,488 shares — an estimated $703K sold.

Acuitas Investments first reported a position in LENZ in Q2 2023 and held it in 4 quarters. The position peaked at $703K in Q1 2024. 65 funds tracked by Wall St. Rank hold LENZ as of Q2 2024.

  • Acuitas Investments reported no remaining LENZ Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Acuitas Investments sold 31,488 LENZ Therapeutics shares in Q2 2024, an estimated $703K.
  • Acuitas Investments first reported a position in LENZ Therapeutics in Q2 2023 and held it in 4 quarters.
  • Acuitas Investments's LENZ Therapeutics position peaked at $703K in Q1 2024.
  • 65 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2024.

Based on Acuitas Investments's 13F filing for Q2 2024, filed 5 Aug 2024.